Multimodal treatment for ADHD among youths in three medicaid subgroups: Disabled, foster care, and low income

Psychiatric Services

Volumn 55, Issue 9, 2004, Pages 1041-1048

  DosReis, Susan ^a,c   Owens, Pamela L ^c,d   Puccia, Karen B ^b   Leaf, Philip J ^c  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; CENTRAL STIMULANT AGENT; HYPNOTIC SEDATIVE AGENT; LITHIUM; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; DISABLED PERSON; FOSTER CARE; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MEDICAID; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; PSYCHOTHERAPY;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMBINED MODALITY THERAPY; DEMOGRAPHY; DISABLED CHILDREN; FEMALE; FOSTER HOME CARE; HUMANS; MALE; MEDICAID; MENTAL DISORDERS; MENTAL HEALTH SERVICES; MID-ATLANTIC REGION; SOCIOECONOMIC FACTORS;

EID: 4444303900     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.55.9.1041     Document Type: Article

References (68)

1. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC, American Psychiatric Association, 1994
2. Mental Health: A Report of the Surgeon General. Rockville, Md, Center for Mental Health Services, National Institute of Mental Health, 1999
3. Rowland AS, Umbach DM, Catoe KE, et al: Studying the epidemiology of attention-deficit hyperactivity disorder: screening method and pilot results. Canadian Journal of Psychiatry 46:931-940, 2001
4. Wolraich ML, Hannah JN, Pinnock TY, et al: Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. Journal of the American Academy of Child and Adolescent Psychiatry 35:319-324, 1996
5. Kelleher KJ, McInerny TK, Gardner WP, et al: Increasing identification of psychosocial problems: 1979-1996. Pediatrics 105: 1313-1321, 2000
6. Zito JM, Safer DJ, dosReis S, et al: Psychotropic practice patterns for youth: a 10-year perspective. Archives of Pediatrics and Adolescent Medicine 157:17-25, 2003
7. Zito JM, Safer DJ, dosReis S, et al: Trends in the prescribing of psychotropic medications to preschoolers. JAMA 283:1025-1030, 2000
8. Olfson M, Gameroff MJ, Marcus SC, et al: National trends in the treatment of attention deficit hyperactivity disorder. American Journal of Psychiatry 160:1071-1077, 2003
9. Zarin DA, Tanielian TL, Suarez AP, et al: Treatment of attention-deficit hyperactivity disorder by different physician specialties. Psychiatric Services 49:171, 1998
10. Bussing R, Zima BT, Belin TR: Variations in ADHD treatment among special education students. Journal of the American Academy of Child and Adolescent Psychiatry 37:968-976, 1998
11. Zarin DA, Suarez AP, Pincus HA, et al: Clinical and treatment characteristics of children with attention-deficit/hyperactivity disorder in psychiatric practice. Journal of the American Academy of Child and Adolescent Psychiatry 37:1262-1270, 1998
12. Zito JM, Safer DJ, dosReis S, et al: Psychotherapeutic medication patterns for youths with attention deficit/hyperactivity disorder. Archives of Pediatrics and Adolescent Medicine 153:1257-1263, 1999
13. Halfon N, Berkowitz G, Klee L: Children in foster care in California: an examination of Medicaid reimbursed health services utilization. Pediatrics 89:1230-1237, 1992
14. DosReis S, Zito JM, Safer DJ, et al: Mental health services for youths in foster care and disabled youths. American Journal of Public Health 91:1094-1099, 2001
15. Halfon N, Berkowitz G, Klee L: Mental health service utilization by children in foster care in California. Pediatrics 89:1238-1244, 1992
16. Takayama JI, Bergman AB, Connell FA: Children in foster care in the state of Washington. JAMA 271:1850-1855, 1994
17. Harman JS, Childs GE, Kelleher KJ: Mental health care utilization and expenditures by children in foster care. Archives of Pediatrics and Adolescent Medicine 154:1114-1117, 2000
18. Dulcan M: Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder: American Academy of Child and Adolescent Psychiatry. Journal of the American Academy of Child and Adolescent Psychiatry 36(suppl 10):85S-121S, 1997
19. Weisz JR, Jensen PS: Efficacy and effectiveness of child and adolescent psychotherapy and pharmacotherapy. Mental Health Services Research 1:125-157, 1999
20. Greenhill LL, Pliszka S, Dulcan MK, et al: Practice parameters for the use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child and Adolescent Psychiatry 41(suppl 2):26S-49S, 2002
21. Safer DJ, Zito JM, Gardner JF: Pemoline hepatotoxicity and post-marketing surveillance. Journal of the American Academy of Child and Adolescent Psychiatry 40:622-629, 2001
22. Burns BJ, Hoagwood K, Mrazek PJ: Effective treatment for mental disorders in children and adolescents. Clinical Child and Family Psychology Review 2:199-254, 1999
23. Pelham WE Jr, Gnagy EM, Greiner AR, et al: Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. Journal of Abnormal Child Psychology 28:507-525, 2000
24. Barkley RA: Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York, Guilford, 1998
25. Bussing R, Zima BT, Perwien AR: Self-esteem in special education children with ADHD: relationship to disorder characteristics and medication use. Journal of the American Academy of Child and Adolescent Psychiatry 39:1260-1269, 2000
26. Frankel F, Cantwell DP, Myatt R, et al: Do stimulants improve self-esteem in children with ADHD and peer problems? Journal of Child and Adolescent Psychopharmacology 9:185-194, 1999
27. Kelly PC, Cohen ML, Walker WO, et al: Self-esteem in children medically managed for attention deficit disorder. Pediatrics 83: 211-217, 1989
28. DosReis S, Zito JM, Safer DJ, et al: Parental perceptions and satisfaction with stimulant medication for ADHD. Journal of Developmental and Behavioral Pediatrics 24:155-161, 2003
29. Bagwell CL, Molina BSG, Pelham WE Jr, et al: Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence. Journal of the American Academy of Child and Adolescent Psychiatry 40:1285-1292, 2001
30. Klassen A, Miller A, Raina P, et al: Attention-deficit hyperactivity disorder in children and youth: a quantitative systematic review of the efficacy of different management strategies. Canadian Journal of Psychiatry 44:1007-1016, 1999
31. Cunningham CE: In the wake of the MTA: charting a new course for the study and treatment of children with attention-deficit hyperactivity disorder. Canadian Journal of Psychiatry 44:999-1006, 1999
32. Jensen PS, Hinshaw SP, Kraemer HC, et al: ADHD comorbidity findings from the MTA Study: comparing comorbid subgroups. Journal of the American Academy of Child and Adolescent Psychiatry 40:147-158, 2001
33. A 14-month randomized clinical triail of treatment strategies for attention-deficit/hyperactivity disorder: the MTA Cooperative Group: Multimodal Treatment Study of Children With ADHD. Archives of General Psychiatry 56:1073-1086, 1999
34. Guevara J, Lozano P, Wickizer T, et al: Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder. Pediatrics 109:733-739, 2002
35. Costello EJ, Mustillo S, Erkanli A, et al: Prevalence and development of psychiatric disorders in childhood and adolescence. Archives of General Psychiatry 60:837-844, 2003
36. Connor DF, Edwards G, Fletcher KE, et al: Correlates of comorbid psychopathology in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 42:193-200, 2003
37. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children With Attention-deficit/hyperactivity disorder. Archives of General Psychiatry 56:1088-1096, 1999
38. Cox ER, Motheral BR, Henderson RR, et al: Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample. Pediatrics 111:237-243, 2003
39. LeFever GB, Dawson KV, Morrow AL: The extent of drug therapy for attention-deficit-hyperactivity disorder among children in public schools. American Journal of Public Health 89:1359-1364, 1999
40. LeFever GB, Hannon PH, Dawson KV, et al: Prevalence of medication use for attention deficit hyperactivity disorder (ADHD): a population-based study of Virginia school children. Pediatric Research 41:14a, 1997
41. Rappley MD, Eneli IU, Mullan PB, et al: Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder. Journal of Developmental and Behavioral Pediatrics 23:23-30, 2002
42. Zito JM, Safer DJ, dosReis S, et al: Methylphenidate patterns among Medicaid youths. Psychopharmacology Bulletin 33:143-147, 1997
43. Chan E, Zhan C, Homer CJ: Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey. Archives of Pediatrics and Adolescent Medicine 156:504-511, 2002
44. Guevara J, Lozano P, Wickizer T, et al: Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics 108:71-78, 2001
45. Lessler JT, Harris BSH: Medicaid as a Source for Postmarketing Surveillance Information, Final Report. Research Triangle Park, NC, Research Triangle Institute, 1984
46. Walkup JT, Boyer CA, Kellermann SL: Reliability of Medicaid claims files for use in psychiatric diagnoses and service delivery. Administration and Policy in Mental Health 27:129-139, 2000
47. Lurie N, Popkin M, Dysken M, et al: Accuracy of diagnoses of schizophrenia in Medicaid claims. Hospital and Community Psychiatry 43:69-71, 1992
48. Steinwachs DM, Stuart ME, Scholle S, et al: A comparison of ambulatory Medicaid claims to medical records: a reliability assessment. American Journal of Medical Quality 13:63-69, 1998
49. Strom BL: Pharmacoepidemiology. New York, John Wiley and Sons, Inc, 1994
50. Rushton JL, Clark SJ, Freed GL: Pediatrician and family physician prescription of selective serotonin reuptake inhibitors. Pediatrics 105:E82, 2000
51. Perrin JM, Kuhlthau K, McLaughlin TJ, et al: Changing patterns of conditions among children receiving supplemental security income disability benefits. Archives of Pediatrics and Adolescent Medicine 153:80-84, 1999
52. Kuhlthau K, Ferris TG, Beal AC, et al: Who cares for Medicaid-enrolled children with chronic conditions? Pediatrics 108:906-912, 2001
53. Rubin DM, Allessandrini EA, Feudtner C, et al: Placement stability and mental health costs for children in foster care. Pediatrics 113:1336-1341, 2004
54. Hochstadt NJ, Jaudes PK, Zimo DA, et al: The medical and psychosocial needs of children entering foster care. Child Abuse and Neglect 11:53-62, 1987
55. Frank G: Treatment needs of children in foster care. American Journal of Orthopsychiatry 50:256-263, 1980
56. Takayama JI, Wolfe E, Coulter KP: Relationship between reason for placement and medical findings among children in foster care. Pediatrics 101:201-207, 1998
57. Kuhlthau K, Perrin JM, Ettner SL, et al: High-expenditure children with supplemental security income. Pediatrics 102: 610-615, 1998
58. Conners CK, Epstein JN, March JS, et al: Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. Journal of the American Academy of Child and Adolescent Psychiatry 40:159-167, 2001
59. Boles M, Lynch FL, DeBar LL: Variations in pharmacotherapy for attention deficit hyperactivity disorder in managed care. Journal of Child and Adolescent Psychopharmacology 11:43-52, 2001
60. Buckley PF: The role of typical and atypical antipsychotic medications in the management of agitation and aggression. Journal of Clinical Psychiatry 60:52-60, 1999
61. Fava M: Psychopharmacologic treatment of pathologic aggression. Psychiatric Clinics of North America 20:427-451, 1997
62. Allison DB, Mentore JL, Heo M, et al: Antipsychotic-induced weight gain: a comprehensive research synthesis. American Journal of Psychiatry 156:1686-1696, 1999
63. Lund BC, Perry PJ, Brooks JM, et al: Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension. Archives of General Psychiatry 58:1172-1176, 2001
64. Bright RA, Avom J, Everitt DE: Medicaid data as a resource for epidemiologic studies: strengths and limitations. Journal of Clinical Epidemiology 42:937-945, 1989
65. Hoagwood K, Kelleher KJ, Feil M, et al: Treatment services for children with ADHD: a national perspective. Journal of the American Academy of Child and Adolescent Psychiatry 39:198-206, 2000
66. Parr JR, Ward A, Inman S: Current practice in the management of attention deficit disorder with hyperactivity (ADHD). Child: Care, Health, and Development 29:215-218, 2003
67. Jensen PS, Hinshaw SP, Swanson JM, et al: Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. Journal of Developmental and Behavioral Pediatrics 22:60-73, 2001
68. Hazelwood E, Bovingdon T, Tiemens K: The meaning of a multimodal approach for children with ADHD: experiences of service professionals, Child: Care, Health, and Development 28:301-307, 2002